Today: 21 May 2026
XRP price slips as Coinbase opposition stalls key U.S. crypto bill — what traders watch next
16 January 2026
1 min read

XRP price slips as Coinbase opposition stalls key U.S. crypto bill — what traders watch next

New York, Jan 16, 2026, 10:11 AM EST — Regular session.

  • XRP dropped roughly 2% after Washington’s efforts to introduce new crypto market regulations stalled.
  • Coinbase’s CEO said the exchange can’t support the bill “in its current form.”
  • Ripple highlighted new regulatory developments in Europe this week.

XRP dropped roughly 2% to $2.06 on Friday, deepening its retreat after a U.S. Senate committee put the brakes on a broad crypto market-structure bill.

This setback is significant since the bill aims to clarify how crypto tokens are regulated in the U.S., a demand the industry has pushed for years. Such moves can swiftly shift sentiment in the large, liquid coins.

This comes amid a hectic policy week for crypto in Washington, where traders had been betting that a workable framework was just around the corner.

Bitcoin slipped roughly 0.8% to near $95,200, while ether dropped about 1.4% to around $3,300, following the broader weakness seen in leading tokens.

The Senate Banking Committee canceled a scheduled markup — where lawmakers hash out and vote on amendments — after Coinbase CEO Brian Armstrong said the exchange couldn’t back the bill as it stands. “We’d rather have no bill than a bad bill,” Armstrong stated, though he expressed hope a deal could still be struck. Reuters

The bill, called the CLARITY Act, aims to define precisely when crypto tokens qualify as securities. It also tackles the ongoing debate over stablecoin rewards—those incentives linked to dollar-pegged tokens that banks warn might siphon deposits away from conventional banking.

The Senate Banking Committee’s calendar update revealed the Jan. 15 executive session to review H.R.3633 has been postponed.

Ripple, steering clear of Capitol Hill distractions, highlighted its licensing progress. This week, the company snagged preliminary approval for an electronic money institution licence in Luxembourg, aiming to broaden its payments services throughout Europe. “The EU was amongst the first major jurisdictions to introduce comprehensive digital assets regulation,” Ripple President Monica Long noted. Ripple

For now, the most immediate risk to XRP is straightforward: if the U.S. bill stalls or is altered in ways opposed by the industry, the market could fall back into uncertainty over which regulator—and which set of rules—will take charge.

Traders are focused on key upcoming deadlines in Congress: the Senate Agriculture Committee aims to release legislative text by Jan. 21, with a committee markup set for Jan. 27. They’re also tracking any new dates from the Banking Committee.

Stock Market Today

  • Stock Market Today: Key Insights for May 21 Trading
    May 20, 2026, 10:27 PM EDT. Stocks in the news and major brokerage calls shape market sentiment as traders prepare for May 21. This report provides a complete trade setup, highlighting critical market movements and strategies. Stay informed with the essential data before entering trades today.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Nvidia CEO Jensen Huang shuts down “God AI” hype — and says AI will still “eat software”
Previous Story

Nvidia CEO Jensen Huang shuts down “God AI” hype — and says AI will still “eat software”

Palantir stock slides in early trade as PLTR volatility, options expiry loom
Next Story

Palantir stock slides in early trade as PLTR volatility, options expiry loom

Go toTop